Steviol glycoside compositions with reduced surface tension
US-12097231-B2 · Sep 24, 2024 · US
Sweetener composition for preventing and improving obesity, containing glycolysis inhibitor ingredient
US2016346305A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016346305-A1 |
| Application number | US-201615234331-A |
| Country | US |
| Kind code | A1 |
| Filing date | Aug 11, 2016 |
| Priority date | Sep 15, 2011 |
| Publication date | Dec 1, 2016 |
| Grant date | — |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to a sweetener composition for preventing or treating obesity containing, as active ingredients, a glucose or D-fructose absorption inhibiting component and a sugar hydrolysis inhibiting sugar or sugar alcohol.
First claim
Opening claim text (preview).
1 . A method for lowering increase of blood glucose level, comprising administering a sweet composition containing D-psicose and tagatose as active ingredients, to the subject. 2 . The method as claimed in claim 1 , wherein the sweetener composition lowers increase of blood glucose level after meal. 3 . The method as claimed in claims 1 , wherein the sweet composition further comprises a high-intensity sweetener. 4 . The method as claimed in claim 3 , wherein the sweet composition comprises at least one high-intensity sweetener selected from the group consisting of steviol glycoside, sucralose, aspartame, Siraitia grosvenori extract, Glycyrrhiza uralensis Fischer extract, and thaumatin. 5 . The method as claimed in claim 3 , wherein the tagatose is present in an amount of 0.01 to 200 times based on the weight of D-psicose, and the high-intensity sweetener is present in an amount of 0.001 to 2 times based on the weight of D-psicose. 6 . The method as claimed in claim 1 , wherein the sweet composition is provided as a beverage. 7 . The method as claimed in claim 1 , wherein the sweet composition is administered after a meal. 8 . The method as claimed in claim 2 , wherein the after meal means within 1 hour after a meal.
Assignees
Inventors
Classifications
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
for glucose homeostasis (pancreatic hormones A61P5/48) · CPC title
Anorexiants; Antiobesity agents · CPC title
Dietetic or nutritional methods, e.g. for losing weight (A23L33/10 takes precedence) · CPC title
Food compositions, function of food ingredients or processes for food or foodstuffs · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US2016346305A1 cover?
- The present invention relates to a sweetener composition for preventing or treating obesity containing, as active ingredients, a glucose or D-fructose absorption inhibiting component and a sugar hydrolysis inhibiting sugar or sugar alcohol.
- Who is the assignee on this patent?
- Cj Cheiljedang Corp
- What technology area does this patent fall under?
- Primary CPC classification A23L27/39. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Thu Dec 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).